Cengild Medical Berhad (KLSE:CENGILD)
Malaysia · Delayed Price · Currency is MYR 0.1950
0.00 (0.00%)
At close: Sep 2, 2026
Cengild Medical Berhad Income Statement
Financials in millions MYR. Fiscal year is July - June.
Millions MYR. Fiscal year is Jul - Jun.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
| 73.21 | 80 | 66.82 | 70.28 | 64.44 | |
Revenue Growth | -8.49% | 19.72% | -4.92% | 9.06% | 1.53% |
Cost of Revenue | 38.61 | 43.12 | 35.75 | 39.55 | 38.39 |
Gross Profit | 34.59 | 36.87 | 31.07 | 30.73 | 26.05 |
Selling, General & Admin | 23.44 | 22.05 | 17.86 | 16.24 | 14.48 |
Other Operating Expenses | -2.93 | - | - | - | - |
Operating Expenses | 21.06 | 22.54 | 17.86 | 16.26 | 14.48 |
Operating Income | 13.53 | 14.33 | 13.21 | 14.46 | 11.57 |
Interest Expense | -0.19 | -0.39 | -0.6 | -0.73 | -0.85 |
Earnings From Equity Investments | 0.69 | 0.47 | -0.35 | - | - |
Other Non Operating Income (Expenses) | - | 3.59 | 4.48 | 3.65 | 1.39 |
EBT Excluding Unusual Items | 14.04 | 18.01 | 16.73 | 17.37 | 12.11 |
Pretax Income | 14.04 | 18.01 | 16.73 | 17.37 | 12.11 |
Income Tax Expense | 2.6 | 4.44 | 4.77 | 4.09 | 2.72 |
Earnings From Continuing Operations | 11.44 | 13.57 | 11.97 | 13.29 | 9.39 |
Earnings From Discontinued Operations | - | -2.51 | -0.89 | - | - |
Net Income | 11.44 | 11.06 | 11.08 | 13.29 | 9.39 |
Net Income to Common | 11.44 | 11.06 | 11.08 | 13.29 | 9.39 |
Net Income Growth | 3.47% | -0.19% | -16.64% | 41.50% | -6.13% |
Shares Outstanding (Basic) | 833 | 833 | 833 | 819 | 644 |
Shares Outstanding (Diluted) | 833 | 833 | 834 | 826 | 645 |
Shares Change | - | -0.11% | 1.00% | 27.94% | 7.56% |
EPS (Basic) | 0.01 | 0.01 | 0.01 | 0.02 | 0.01 |
EPS (Diluted) | 0.01 | 0.01 | 0.01 | 0.02 | 0.01 |
EPS Growth | 3.20% | -0.19% | -17.39% | 10.46% | -12.59% |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | -68.25 | -21.18 | -2.8 | 11.78 | 14.9 |
Free Cash Flow Per Share | -0.08 | -0.03 | -0.00 | 0.01 | 0.02 |
Dividend Per Share | 0.004 | 0.010 | 0.007 | 0.007 | 0.004 |
Dividend Growth | -62.89% | 31.08% | 0% | 100.00% | - |
Gross Margin | 47.26% | 46.10% | 46.50% | 43.72% | 40.42% |
Operating Margin | 18.48% | 17.91% | 19.77% | 20.58% | 17.95% |
Profit Margin | 15.63% | 13.82% | 16.58% | 18.91% | 14.57% |
Free Cash Flow Margin | -93.22% | -26.48% | -4.19% | 16.77% | 23.12% |
EBITDA | 18.36 | 19.39 | 15.76 | 16.33 | 14.56 |
EBITDA Margin | 25.08% | 24.23% | 23.58% | 23.23% | 22.60% |
D&A For EBITDA | 4.83 | 5.06 | 2.55 | 1.87 | 2.99 |
EBIT | 13.53 | 14.33 | 13.21 | 14.46 | 11.57 |
EBIT Margin | 18.48% | 17.91% | 19.77% | 20.58% | 17.95% |
Effective Tax Rate | 18.50% | 24.65% | 28.48% | 23.52% | 22.48% |